Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON42611Active, not recruiting
Trial of tapentadol and pregabalin in Neuralgia (3 arms), sponsored by Grünenthal GmbH. Primary endpoints: Pain scores after intradermal capsaicin injection, Area of secondary mechanical hyperalgesia and 1 more. Started Sep 2015; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON42611.